Teva sues Eli Lilly again after FDA approves migraine drug

01-10-2018

Teva sues Eli Lilly again after FDA approves migraine drug

mraoraor / iStockphoto.com

Teva has once again taken Eli Lilly to court over a migraine drug, just hours after Eli Lilly gained Food and Drug Administration (FDA) approval to market Emgality (galcanezumab-gnlm).


Eli Lilly, Teva, patent, patent infringement, Emgality, migraine drug, Ajovy, FDA approval, biotech, biologic, 


LSIPR